Discover 3,580 paid clinical trials in Irvine, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trials in Irvine address a diverse range of conditions, from mental health disorders and neurological diseases to skin conditions and cardiovascular issues. As one of California’s thriving research hubs, the city provides participants with a chance to explore cutting-edge therapies and receive specialized care, all while contributing to the advancement of medical science in their region.
Filter
2
Filter results
Results: 3,580
Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC
for
HNSCC, Head and Neck Squamous Cell Carcinoma
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18 - 70+
Code: NCT06693323
Phase2, Recruiting
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
for
Brain and Central Nervous System Tumors
Location: Encinitas CA
Sponsor: San Diego Pacific Oncology & Hematology Associates
Sex: All
Age: 18+
Code: NCT00492687
Phase2, Recruiting
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
for
Carcinoma, Non-Small Cell Lung
Location: Los Angeles CA, Lone Tree CO, Urbana IL, Lexington KY,
Sponsor: Genprex, Inc.
Sex: All
Age: 18+
Code: NCT04486833
Phase1, Phase2, Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Location: Orange CA, Las Vegas NV, Oklahoma City OK, Omaha NE,
Sponsor: University Medical Center Groningen
Sex: Female
Age: 18+
Code: NCT05076942
Phase2, Recruiting
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
for
Acute Myeloid Leukemia,
Location: Orange CA, Salt Lake City UT, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05886049
Phase1, Recruiting
18F-DCFPyL PET-CT Scan and Prostate Cancer
for
Prostate Cancer Adenocarcinoma
Location: Los Angeles CA
Sponsor: Lida Jafari
Sex: Male
Age: 18+
Code: NCT03852654
Phase2, Phase3, Recruiting
Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer
for
Lung Cancer
Location: Los Angeles CA, Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06427954
Recruiting
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
for
Breast Cancer, Sarcoma, Gastric Cancer, Lung Cancer,
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT06580002
Phase2, Recruiting
Patient-Derived Xenografts to Reduce Cancer Health Disparities
for
Bladder Carcinoma, Gastric Carcinoma,
Location: Orange CA, Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 21 - 70+
Code: NCT04410302
Recruiting
Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
for
Alzheimer Disease, Early Onset, Mild Cognitive Impairment,
Location: Los Angeles CA, Providence RI
Sponsor: Butler Hospital
Sex: All
Age: 50 - 70+
Code: NCT04500847
Phase1, Recruiting
Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors
for
Advanced Refractory Solid Tumors,
Location: California City CA, Colorado Springs CO, Texas City TX,
Sponsor: Cosmo Technologies Ltd
Sex: All
Age: 18+
Code: NCT03863145
Early_phase1, Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML